ArriVent BioPharma AVBP Institutional Ownership

Updated Oct 11, 2026

ArriVent BioPharma, Inc. (NASDAQ:AVBP) was held by 159 institutional investors that filed 13F reports for the quarter ended June 30, 2026.

• These investors held 95.46% of ArriVent BioPharma's outstanding shares at the end of Q2 2026, up from 92.90% in Q1 2026.
• Total shares held in AVBP rose 9.59% from Q1 2026; the number of holders rose 65.62% from Q2 2025.
• Looking at the 159 holders of AVBP individually, 108 added to their positions, 31 reduced their stakes and 20 left their positions unchanged.
• The aggregate institutional position in ArriVent BioPharma was 46.13Mn shares at the end of Q2 2026, up 4.04Mn from the prior quarter and up 12.64Mn from a year earlier.
• Montanova Capital, LLC held the largest position in AVBP at 4.52Mn shares as of June 30, 2026, or 9.35% of shares outstanding.
• Holders that added the most shares of ArriVent BioPharma in Q2 2026 were Vivo Capital, LLC (+796.18K shares), BlackRock, Inc. (+720.1K shares), Logos Global Management LP (+650K shares), D. E. Shaw & Co., Inc. (+503.22K shares) and Infinitum Asset Management, LLC (+289.46K shares).
• On the other side, among holders that kept a position in ArriVent BioPharma, the largest reductions in Q2 2026 came from Novo Holdings A/S (-442.14K shares), FMR LLC (-237.17K shares), Point72 Asset Management, L.P. (-181.4K shares), Nomura Holdings Inc (-87.43K shares) and Affinity Asset Advisors, LLC (-50K shares).
• According to Business Quant data, the leading holders of AVBP for Q2 2026 were Montanova Capital, LLC (4.52Mn shares), Infinitum Asset Management, LLC (4.44Mn shares), HHLR Advisors, LTD. (3.93Mn shares), BlackRock, Inc. (3.25Mn shares), OrbiMed Advisors LLC (3.03Mn shares), FMR LLC (2.78Mn shares), Octagon Capital Advisors LP (1.97Mn shares), Vanguard Capital Management LLC (1.77Mn shares), Sofinnova Investments, Inc. (1.7Mn shares) and State Street Corp (1.69Mn shares).